Zhang, Xueshu, et al., “Preclinical Pharmacology of the Natural Product Anticancer Agent Bryostatin 1, an Activator of Protein Kinase C1,” Cancer Research, 56:802-808 (1996). |
Hardy, J., “Molecular Genetics of Alzheimer's Disease,” Acta Neurol Scand, 165:13-17, (1996). |
Webb, Benjamin L.J., et al., “Protein Kinase C Isoenzymes: A Review of Their Structure, Regulation and Role in Regulating Airways Smooth Muscle Tone and Mitogenesis,” British Journal of Pharmacology, 130:1433-1452 (2000). |
Tanzi, Rudolph E., et al., “The Gene Defects Responsible for Familial Alzheimer's Disease,” Neurolobiology of Disease, 3:159-168 (1996). |
Goekjian, Peter G., et al., “Protein Kinase C in the Treatment of Disease: Signal Transduction Pathways, Inhibitors, and Agents in Development,” Current Medicinal Chemistry, 6:877-903 (1999). |
Connolly, Gerald P., “Fibroblast Models of Neurological Disorders: Fluorescence Measurement Studies,” TIPS, 19:171-177 (1998). |
Selkoe, Dennis J., “Alzheimer's Disease: Genes, Proteins, and Therapy,” Physiological Reviews, 81(2):741-766 (2001). |
Etcheberrigaray, Rene, et al., “Calcium Responses are Altered in Fibroblasts from Alzheimer's Patients and Pre-symptomatic PS1 Carriers; A Potential Tool for Early Diagnosis,” Alzheimer's Reports, 3(5&6):305-312 (2000). |
Ibarreta, Dolores, et al., “Benzolactam (BL) Enhances sAPP Secretion in Fibroblasts and in PC12 Cells,” Ageing, 10(5):1035-1040 (1999). |
Small, David, et al., “Alzheimer's Disease and the Amyloid β Protein: What is the Role of Amyloid?,” Journal of Neurochemistry, 73(2):443-449 (1999). |
Nan, Fajun, et al., “Dual Function Glutamate-Related Ligands: Discovery of a Novel, Potent Inhibitor of Glutamate Carboxypeptidase II Possessing mGluR3 Agonist Activity,” Journal of Medicinal Chemistry, 43(5): 772-774 (2000). |
Jolly-Tometta, Camille, et al., Regulation of Amyloid Precursor Protein (APP) Secretion by Protein Kinase Cα in Human Ntera 2 Neurons (NT2N); Biochemistry, 39(25):7428-7435 (2000). |
Masliah, Eliezer, “Role of Amyloid Precursor Protein in the Mechanisms of Neurodegeneration in Alzheimer's Disease,” Laboratory Investigation, 77(3): 197-209 (1997). |
Ghosh, Arun, K., et al, “Design of Potent Inhibitors for Human Brain Memapsin 2 (β-Secretase),” J. Am. Chem. Soc., 122(14):3522-3523 (2000). |
Mutter, Roger, et al., “Chemistry and Clinical Biology of the Bryostatins,” Bioorganic & Medicinal Chemistry, 8:1841-1860 (2000). |
Varterasian, Mary L., et al., “Phase II Trial of Bryostatin 1 in Patients with Relapsed Low-Grade Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia,” Clinical Cancer Research, 6:825-828 (2000). |
Hennings, Henry, et al., “Bryostatin 1, an Activator of Protein Kinase C, Inhibits Tumor Promotion by Phorbol Esters in SENCAR Mouse Skin,” Carcinogenesis, 8(9):1343-1346 (1987). |
Szallasi, Zoltan, et al., “Differential Regulation of Protein Kinase C Isozymes by Cryostatin 1 and Phorbol 12-Myristate 13-Acetate in NIH 3T3 Fibroblasts,” Journal of Biological Chemistry, 269(3):2118-2124 (1994). |